European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research project
Abstract Background The care of patients with brain tumors is a complex task that requires quality standards and quality assurance indicators. In the present study, several quality indicators were evaluated in routine clinical care. Methods The EORTC Brain Tumor Group (BTG) developed quality indicators from published guidelines and tested them in 19 BTG sites across Europe. Each site extracted data from the files of 20 randomly selected glioblastoma patients diagnosed in 2018. Associations between quality indicators, site characteristics and median overall survival (mOS) were examined. Results A total of 364 patient files were evaluated at 19 sites. Excellent compliance was observed in the documentation of neuropathology report with isocitrate dehydrogenase (IDH) status (92.0%), O6-methylguanine DNA methyltransferase promoter methylation (MGMT) status (78.0%), multidisciplinary case discussion (95.3 %), extent of resection (87.1%), and radiotherapy details (96.9%) as well as consent to chemotherapy (75.5%). Performance was not as good for early postoperative MRI (67.2%), psycho-oncological care (40.5%), avoiding antineoplastic therapy in the last weeks of life (63.1%) and early referral to palliative services (23.5%). Timely start of radiotherapy (P = .0153), the presence of a radiotherapy report in the medical record (P = .0077), and patient education on oral chemotherapy (P = .0002) were positively associated with mOS, while early referral to palliative care was associated with shorter mOS (P < .0001). Conclusions The quality indicators tested in this research project performed with some variability between sites. Significant associations between individual quality indicators and mOS were observed. The proposed quality indicators should be validated prospectively.
Authors
- E. Razis
- Dieta Brandsma (ORCID: https://orcid.org/0000-0001-7998-9904)
- Michael Weller (ORCID: https://orcid.org/0000-0002-1748-174X)
- Petter Brandal (ORCID: https://orcid.org/0000-0003-0259-495X)
- Filip De Vos (ORCID: https://orcid.org/0000-0002-9082-5991)
- Thierry Gorlia
- Tomáš Kazda (ORCID: https://orcid.org/0000-0001-7288-8975)
- Peter Hau (ORCID: https://orcid.org/0000-0003-3894-5053)
- Andrea Di Cristofori (ORCID: https://orcid.org/0000-0002-6148-1894)
- Egils Valeinis (ORCID: https://orcid.org/0009-0009-9510-3232)
- Patrick Roth (ORCID: https://orcid.org/0000-0003-3897-214X)
- Nicolaus Andratschke (ORCID: https://orcid.org/0000-0003-3647-5916)
- Anastasia Vernadou
- Matthias Preusser (ORCID: https://orcid.org/0000-0003-3541-2315)
- Naureen Keric (ORCID: https://orcid.org/0000-0001-8457-0059)
- Giuseppe Lombardi (ORCID: https://orcid.org/0000-0003-1316-2132)
- Annika Malmström (ORCID: https://orcid.org/0000-0001-8410-4939)
- Vittoria Espeli (ORCID: https://orcid.org/0000-0001-5374-129X)
- Jordi Bruna (ORCID: https://orcid.org/0000-0001-6895-5047)
- Brigitta G. Baumert (ORCID: https://orcid.org/0000-0001-8871-4654)
- Maximilian J. Mair (ORCID: https://orcid.org/0000-0002-6537-3874)
- Philipp Lohmann (ORCID: https://orcid.org/0000-0002-5360-046X)
- Ana Azevedo (ORCID: https://orcid.org/0000-0002-7368-9609)
- Ludo Vanopdenbosch
- Markus W. Groß
- Jean‐François Daisne (ORCID: https://orcid.org/0000-0001-8584-4189)
Institutions
- Linköping University (SE)
- Oslo University Hospital (NO)
- Forschungszentrum Jülich (DE)
- Johannes Gutenberg University Mainz (DE)
- University of Zurich (CH)
- Dutch Cancer Society (NL)
- Bellvitge University Hospital (ES)
- University Hospital of Basel (CH)
- The Netherlands Cancer Institute (NL)
- University Medical Center Utrecht (NL)
- University Hospital Regensburg (DE)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Hospital Base (CL)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Ente Ospedaliero Cantonale (CH)
- Pauls Stradiņš Clinical University Hospital (LV)
- University Hospital of Zurich (CH)
- Istituto Oncologico Veneto (IT)
- Azienda Ospedaliera San Gerardo (IT)
- Oncode Institute (NL)
- Masaryk Memorial Cancer Institute (CZ)
- Hygeia Hospital (GR)
- AZ Sint-Jan (BE)
- European Organisation for Research and Treatment of Cancer (BE)
- Samueli Institute (US)
- Instituto Português de Oncologia de Coimbra Francisco Gentil (PT)
- Kantonsspital Graubünden (CH)
- Medical University of Vienna (AT)
- Catholic University of America (US)
- RWTH Aachen University (DE)
- KU Leuven (BE)
Publication Details
- Journal
- Neuro-Oncology Practice
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1093/nop/npaf103
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00